Arnulfo Pantoja v. HHS - Tdap, Guillain-Barré syndrome (2021)

Arnulfo Pantoja filed a petition on February 23, 2021, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from Guillain-Barré syndrome (GBS) as a result of receiving a Tetanus-diphtheria-acellular pertussis (Tdap) vaccination on October 22, 2017.

Respondent denied that the vaccine caused the alleged GBS or any other injury. However, both parties entered into a stipulation dated February 23, 2021, agreeing that the issues could be settled and that a decision should be entered awarding Petitioner compensation.

The stipulation awarded a total of $146,737.45 in compensation, including $132,265.99 for pain and suffering, lost wages, and past unreimbursable expenses, and additional amounts for unreimbursed medical expenses. The Special Master reviewed the file and adopted the stipulation as the decision, awarding the requested amounts.

Judgment was to be entered accordingly.